Respiratory symptom relief related to reduction in cigarette use

Journal of General Internal Medicine

Volumn 20, Issue 10, 2005, Pages 889-894

  Stein, Michael D ^a,b   Weinstock, Marjorie C ^a   Herman, Debra S ^a   Anderson, Bradley J ^a  

^a BROWN UNIVERSITY   (United States)

^b RHODE ISLAND HOSPITAL   (United States)

Author keywords

Cigarettes; Methadone; Nicotine; Quality of life; Symptoms

Indexed keywords

METHADONE;

ADULT; ARTICLE; ASTHMA; BEHAVIOR THERAPY; CIGARETTE SMOKING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; EMPHYSEMA; FEMALE; FOLLOW UP; HUMAN; INTERVIEW; MALE; NICOTINE REPLACEMENT THERAPY; RACE DIFFERENCE; RANDOMIZED CONTROLLED TRIAL; RESPIRATORY TRACT DISEASE; SCORING SYSTEM; SEX DIFFERENCE; SMOKING CESSATION;

ADULT; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; METHADONE; RESPIRATORY TRACT DISEASES; SMOKING CESSATION;

EID: 28444441626     PISSN: 08848734     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1525-1497.2005.0190.x     Document Type: Article

References (24)

1. Abrams DB, Orleans CT, Niaura RS, Goldstein MG, Velicer W, Prochaska JO. Treatment issues: towards a stepped-care model. Tob Control. 1993;2:317-37.
2. Irvin JE, Brandon TH. The increasing recalcitrance of smokers in clinical trials. Nicotine Tob Res. 2000;2:79-84.
3. Hughes JR. Applying harm reduction to smoking. Tob Control. 1995;4: S33-8.
4. Jimenez Ruiz C, Kunze M, Fagerstrom KO. Nicotine replacement: a new approach to reducing tobacco-related harm. Eur Respir J. 1998;11: 473-9.
5. Paoletti P, Fornai E, Maggiorelli F, et al. Importance of baseline cotinine plasma values in smoking cessation: results from a double-blind study with nicotine patch. Eur Respir J. 1996;9:643-51.
6. Hughes JR, Lindgren PG, Connett JE, Nides MA. Smoking reduction in the lung health study. Nicotine Tob Res. 2004;6:275-80.
7. Fagerstrom KO, Tejding R, Westin A, Lunnell E. Aiding reduction of smoking with nicotine replacement medications: hope for the recalcitrant smokers. Tob Control. 1997;6:311-6.
8. Bolliger CT, Zellweger JP, Danielsson T, et al. Smoking reduction with oral nicotine inhalers: double-blind, randomized clinical trial of efficacy and safety. Br Med J. 2000;321:329-33.
9. Clarke J, Stein M, McGarry K, Gogineni A. Interest in smoking cessation among injection drug users. Am J Addict. 2001;10:159-66.
10. Hser YI, McCarthy WJ, Anglin MD. Tobacco use as a distal predictor of mortality among long-term narcotic addicts. Prev Med. 1994;23:61-9.
11. Manley M, Epps RP, Husten C, Glynn T, Shoplande D. Clinical interventions in tobacco control. A national cancer institute training program for physicians. JAMA. 1991;266:3172-3.
12. Miller WR, Rollnick S. Motivational Interviewing: Preparing People for Change. 2nd edn. New York: Guilford Press; 2002.
13. Ferris BG. Epidemiology standardization project (American Thoracic Society). Am Rev Respir Dis. 1978;118:1-120.
14. Helsing KJ, Comstock GW, Speizer FE, et al. Comparison of three standardized questionnaires on respiratory symptoms. Am Rev Respir Dis. 1979;120:1221-31.
15. Sobell LC, Sobell MB. Timeline Follow-Back Users Guide: A Calendar Method for Assessing Alcohol and Drug Use. Toronto, ON, Canada: Addiction Research Foundation: 1996.
16. Heatherton TF, Kozlowski LT, Frecker RC, Fagerstorm KO. The fagerström test for nicotine dependence: a revision of the fagerström tolerance questionnaire. Br J Addict. 1991;86:1119-27.
17. StataCorp. Stata Statistical Software: Release 8.0. College Station, Tex: Stata Corporation; 2003.
18. Warner KE, Slade J, Sweanor LLB. The emerging market for long-term nicotine replacement. JAMA. 1997;278:1087-92.
19. Hayaki J, Anderson BJ, Stein MD. Perceptions of health risk susceptibility among methadone maintained smokers. J Addictive Dis. 2005; 24:73-84.
20. Stein MD, Anderson BJ. Nicotine and drug interaction expectancies among methadone maintained cigarette smokers. J Subst Abuse Treat. 2003;24:357-61.
21. Bolliger CT, Zellweger JP, Danielsson T, et al. Influence of long-term smoking reduction on health risk markers and quality of life. Nicotine Tob Res. 2002;4:433-9.
22. Riley W, Jerome A, Behar A, Weil J. Computer and manual self-help behavioral strategies for smoking reduction: initial feasibility and one-year follow-up. Nicotine Tob Res. 2002;S183-8.
23. Stellman SD, Muscat JE, Thomson S, Hoffman D, Wynder EL. Risk of squamous cell carcinoma and adenocarcinoma of the lung in relation to lifetime filter cigarette smoking. Cancer. 1997;80:382-8.
24. Patrick DL, Cheadle A, Thompson DC, Diehr P, Koepsell T, Kinne S. The validity of self-reported smoking: a review and meta-analysis. Am J Public Health. 1994;84:1086-93.